What is Neurosoft Bioelectronics?
Neurosoft Bioelectronics is a pioneering neurotechnology firm dedicated to the development of advanced, minimally invasive brain-computer interface (BCI) systems. The company's core innovation lies in its ultra-soft and flexible electrode technology, engineered for safe and effective interfacing with delicate neural tissues. These sophisticated recording technologies are poised to significantly advance clinical research and pave the way for future neuro-therapeutic applications, addressing critical needs in understanding and interacting with the human brain.
How much funding has Neurosoft Bioelectronics raised?
Neurosoft Bioelectronics has raised a total of $7.5M across 1 funding round:
Seed
$7.5M
Seed (2026): $7.5M with participation from Protocol Labs, Connecticut Innovations, and IAG Capital Partners
Key Investors in Neurosoft Bioelectronics
Protocol Labs
Protocol Labs is a research and development lab focused on creating software systems and network protocols to tackle significant technological challenges through innovation and an open-source approach.
Connecticut Innovations
Connecticut Innovations is the state's strategic venture capital arm, providing financing and guidance to innovative companies, with dedicated funds for sectors including biosciences.
IAG Capital Partners
IAG Capital Partners is a venture capital firm specializing in leading investment rounds from seed to Series C, providing financial support to innovative companies at various stages of their development.
What's next for Neurosoft Bioelectronics?
With this significant Seed capital infusion, Neurosoft Bioelectronics is strategically positioned to accelerate its research and development initiatives. The company is expected to focus on refining its BCI technology, expanding its clinical validation studies, and potentially scaling its manufacturing capabilities. This latest round of financing, characterized as a major strategic investment, signals a strong commitment from its backers to support the company's long-term vision of transforming neuro-interfacing for both research and therapeutic purposes. The company's trajectory suggests a focus on achieving key milestones necessary for future growth and market penetration in the competitive neurotech landscape.
See full Neurosoft Bioelectronics company page
